PH11041A - 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof - Google Patents

3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof

Info

Publication number
PH11041A
PH11041A PH14508A PH14508A PH11041A PH 11041 A PH11041 A PH 11041A PH 14508 A PH14508 A PH 14508A PH 14508 A PH14508 A PH 14508A PH 11041 A PH11041 A PH 11041A
Authority
PH
Philippines
Prior art keywords
phenethylamine
dihydroxy
salts
alkyl
substituted phenyl
Prior art date
Application number
PH14508A
Other languages
English (en)
Inventor
J Mills
R Tuttle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH11041(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH11041A publication Critical patent/PH11041A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH14508A 1972-04-12 1973-04-12 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof PH11041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
PH11041A true PH11041A (en) 1977-10-25

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
PH14508A PH11041A (en) 1972-04-12 1973-04-12 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en])
KR (1) KR790000113B1 (en])
AR (1) AR203822A1 (en])
AT (1) AT323719B (en])
AU (1) AU472734B2 (en])
BE (1) BE798051A (en])
BG (1) BG23001A3 (en])
CA (1) CA1018188A (en])
CH (2) CH580563A5 (en])
CS (2) CS190448B2 (en])
CY (1) CY963A (en])
DD (1) DD107670B3 (en])
DE (1) DE2317710C2 (en])
DK (1) DK142750C (en])
ES (1) ES413639A1 (en])
FR (1) FR2182947B1 (en])
GB (1) GB1392674A (en])
HK (1) HK50178A (en])
HU (2) HU166213B (en])
IE (1) IE37511B1 (en])
IL (1) IL42016A (en])
KE (1) KE2870A (en])
MY (1) MY7800381A (en])
NL (1) NL174459C (en])
PH (1) PH11041A (en])
PL (2) PL90695B1 (en])
RO (2) RO65105A (en])
SE (1) SE399064B (en])
SU (1) SU496719A3 (en])
YU (2) YU36483B (en])
ZA (1) ZA732136B (en])

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en]) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
EP0071399A3 (en) * 1981-07-22 1983-12-07 Syntex (U.S.A.) Inc. Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (en]) * 1989-12-18 1991-08-23
EP0613879A4 (en) * 1991-05-20 1995-05-03 Tsumura & Co PHELLODENDRINE ANALOG COMPOUNDS AS EFFECTIVE COMPONENTS IN SUPPRESSORS OF THE ALLERGY TYPE IV.
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ES2535975T3 (es) 2002-10-03 2015-05-19 Novaremed Ltd. Compuestos para su uso en el tratamiento de enfermedades autoinmunitarias, enfermedades inmunoalérgicas y rechazo de trasplantes de órganos o tejidos
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
EP2458983B1 (en) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
US20170197977A9 (en) * 2011-08-25 2017-07-13 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
CA2938212C (en) 2014-01-31 2023-03-14 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
JP7218306B2 (ja) 2017-05-15 2023-02-06 コグニション セラピューティクス インク． 神経変性疾患を治療するための組成物
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
DD107670B3 (de) 1988-04-06
GB1392674A (en) 1975-04-30
KE2870A (en) 1978-09-01
HU167597B (en]) 1975-11-28
AU5438573A (en) 1974-10-17
RO65105A (ro) 1980-01-15
NL7305097A (en]) 1973-10-16
SU496719A3 (ru) 1975-12-25
DE2317710C2 (de) 1983-08-04
JPS5825656B2 (ja) 1983-05-28
IL42016A0 (en) 1973-06-29
HU166213B (en]) 1975-02-28
DE2317710A1 (de) 1973-10-18
HK50178A (en) 1978-09-15
CS190448B2 (en) 1979-05-31
CA1018188A (en) 1977-09-27
DK142750C (da) 1981-08-17
DK142750B (da) 1981-01-12
AT323719B (de) 1975-07-25
YU37113B (en) 1984-08-31
PL90695B1 (en]) 1977-01-31
JPS6221343B2 (en]) 1987-05-12
ZA732136B (en) 1974-03-27
JPS497237A (en]) 1974-01-22
CY963A (en) 1978-12-22
CH569691A5 (en]) 1975-11-28
BG23001A3 (bg) 1977-05-20
IE37511B1 (en) 1977-08-03
KR790000113B1 (en) 1979-03-20
JPS58131945A (ja) 1983-08-06
CH580563A5 (en]) 1976-10-15
NL174459C (nl) 1984-06-18
DD107670A5 (de) 1974-08-12
YU36483B (en) 1984-02-29
PL94207B1 (en]) 1977-07-30
ES413639A1 (es) 1976-01-16
YU321279A (en) 1983-04-27
YU97673A (en) 1982-02-25
FR2182947A1 (en]) 1973-12-14
MY7800381A (en) 1978-12-31
SE399064B (sv) 1978-01-30
BE798051A (fr) 1973-10-11
CS190406B2 (en) 1979-05-31
IL42016A (en) 1976-05-31
FR2182947B1 (en]) 1976-07-02
AR203822A1 (es) 1975-10-31
RO70892A (ro) 1982-02-26
NL174459B (nl) 1984-01-16
AU472734B2 (en) 1976-06-03

Similar Documents

Publication Publication Date Title
PH11041A (en) 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof
KE2930A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
CA1011741A (en) 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides and related compounds
PH12617A (en) Aminobenzyl-amides and salts thereof
KE2670A (en) 1,2,3,-thiadiazole derivatives
PH12918A (en) 1,3-dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof
IL36949A (en) Substituted,2,2-diaryl-4-piperidinobutyramides and salts thereof and their preparation
AU3031771A (en) New 2 amino-4-phenyl-thiazoles and their addition salts
GB1406961A (en) 2,4,7-trioxopteridine derivatives
ZA734996B (en) Oral composition
GB1402046A (en) 11,12-epoxyerythromycins
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
IL48667A0 (en) 4alpha-aryl-1,3-diketo-trans-decahydroisoquinolines and 4alpha-aryl-1,3-diketo-1,2,3,4,4alpha,5,6,7-octahydroisoquinolines and their preparation
JPS5119733A (en) Nn arukirudai 3 kyuamiruaminno seiho
HK15179A (en) 2,6-diaminoneburlarine derivatives
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
AU5852873A (en) Cardenolide-3-%2@-desoxy-glycosides<
IL42431A0 (en) New substituted-quinolizinium salts and their preparation
AU6046473A (en) 1-aryl-2-arylalkyl-3-or-4%4@-%substituted-alkyl<-piperazino- 1@<-butanols- or-butenes-1
IL36977A0 (en) 2,6-methano-3-benzazocines and their preparation
IL43436A0 (en) 11,12-secoprostaglandins and their manufacture
GB1404278A (en) 15,17a-unsubstituted-d-homosteroids
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
GB1400789A (en) 1,1-azobis-benzimidazolium salts
PH10716A (en) O(-dl-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts